ErgoMed, Inc. – FDA 483, Nov 5, 2021
ErgoMed, Inc. in San Antonio, TX, a specification developer, was cited with six observations during an FDA inspection from November 3-5, 2021. The inspection revealed significant deficiencies in the firm's quality system, including a lack of established procedures for complaints, CAPA, purchasing controls, quality audits, MDRs, and document control. Many of these issues were repeat observations from a previous inspection in 2019, indicating a persistent failure to implement adequate quality management systems.
ID · bdfb065c-ba3c-416b-83ef-e3cfe4b1eccc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.